HOME | CONTACT | BLOG | SITE MAP   

Press Releases

Vet-Stem, Inc. CEO announces hiring of President and Chief Commercial Officer (Dr. Alexis Nahama)

Leading Regenerative Veterinary Medicine company, Vet-Stem, Inc., CEO announced the hiring of President and Chief Commercial Officer, Alexis Nahama, DVM.

January 15, 2015 --

Poway, California – January 15th, 2015 – Leading Regenerative Veterinary Medicine company, Vet-Stem, Inc., CEO announced the hiring of President and Chief Commercial Officer, Alexis Nahama, DVM.

 

“After ten years of market presence, serving early adopter and progressive veterinarians, we are ready to take our company to the next level. We are heavy on science, and have engaged in the development of our next generation of therapeutic solutions, including working with the FDA towards obtaining approval for the first veterinary cellular therapy product to be used in helping dogs affected by osteoarthritis. In addition to its aim of reducing the pain of osteoarthritis, this therapy has the potential to impact the progression of the disease, and to promote tissue regeneration. Given the complexities of such developments, I have decided to focus most of my time to our research programs. I needed a great partner to take on the current operations and focus our commercial approach”, said Dr Bob Harman (CEO).

 

Dr. Harman and the board of directors announced the appointment of Dr. Alexis Nahama as the new Vet-Stem, Inc.’s President and Chief Commercial Officer.

 

Dr. Nahama, former head of marketing for VCA Inc. (Nasdaq: Woof), brings two decades of global veterinary industry experience with him, ranging from clinical development to managing some of the most influential brands in animal health.

 

“Our current technology has helped over 10,000 dogs, horses and cats through processing of their own fat tissue to extract stem cells that are then injected in painful joints, tendons or ligaments, but many owners are still unaware we have a possible solution for their animal’s need. Although not inexpensive, (great breakthrough technologies seldom are) this therapeutic approach is already available through many veterinarians today!” said Dr Nahama.

 

“Vet-Stem Inc., despite its’ relatively small size has the potential to dramatically change the way veterinarians address difficult diseases in the not so distant future. In a world of giant corporations, this company will be truly disruptive and benefit countless patients worldwide. It is with great pride and excitement that I take on these responsibilities and join this amazingly smart and dedicated group of people”,added Dr. Nahama.

 

 “Alexis’ passion for helping pet owners and veterinarians, coupled with his extensive knowledge of the veterinary industry and his marketing expertise, is exactly what we need to succeed”, stated Dr. Harman. “I am happy to welcome him to be part of our leadership team.”

 





< Back to Press Releases     

 


  • Success Stories
    News
    Videos
    Blog
    Press Releases
    Facebook
    Twitter
     


      COMPANY
    Management
    Investors
    Contact Us
    Careers
    Privacy Policy
    SCIENCE
    FAQs
    Literature Refs
    Safety
    PET & HORSE OWNERS
    Dogs & Cats
    Horses
    Locate a Vet
    FAQs
    VETERINARIANS
    Vet Login /
    Credentialing

    Dogs & Cats
    Horses
    FAQs
    MEDIA ROOM
    Press Releases
    Success Stories
    News
    Videos
    Blog
    LOCATE A VET

    CONTACT US
     

    COPYRIGHT 2011 VETSTEM BIOPHARMA. ALL RIGHTS RESERVED.
    12860 Danielson Court, Suite B, Poway, CA 92064 Phone: 858-748-2004 or 888-387-8361